Skip to main navigation
Skip to search
Skip to main content
Luxembourg Institute of Health Home
Search content at Luxembourg Institute of Health
Home
Profiles
Research units
Research output
Projects
Equipment
Datasets
Transmission of HIV-1 drug resistance
Laura Marije Hofstra
, Jen Claude Schmit
, Annemarie M.J. Wensing
*
*
Corresponding author for this work
Infection and Immunotherapy Research
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
peer-review
1
Citation (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Transmission of HIV-1 drug resistance'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
HIV Drug Resistance
100%
HIV Transmission
100%
Transmitted Drug Resistance
100%
Antiretroviral Therapy
66%
Drug Class
50%
Resource-limited Settings
50%
Drug Resistance
33%
Virological Failure
33%
NNRTI Resistance
33%
Developed Countries
16%
Drug Resistance mutations
16%
Newly Diagnosed
16%
Current Guidelines
16%
High Prevalence
16%
Risk Behavior
16%
PMTCT
16%
Primary Resistance
16%
Resistance Development
16%
Low-to-moderate
16%
First-line Antiretroviral Therapy
16%
Drug Susceptibility Testing
16%
Genetic Barrier
16%
Resistance Resistance
16%
Access to Therapy
16%
Resistance Increase
16%
Failure Current
16%
Class Group
16%
Virological Monitoring
16%
Antiretroviral Therapy Regimens
16%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Drug Resistance
100%
Prevalence
45%
Antiretroviral Therapy
45%
Nonnucleoside Reverse Transcriptase Inhibitor
18%
Infection
9%
High Risk Population
9%
Resistance Mutation
9%
High Risk Behavior
9%
Genetics
9%
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Drug Resistance
100%
Prevalence
45%
Infectious Disease
9%
Human Immunodeficiency Virus
9%
High Risk Population
9%
Infection
9%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Drug Resistance
100%
Prevalence
45%
Nonnucleoside Reverse Transcriptase Inhibitor
18%
Infection
9%